ARTICLE | Company News
Champions Biotechnology, Teva deal
December 13, 2010 8:00 AM UTC
Champions will use its Biomerk Tumorgraft platform to test the anti-tumor effectiveness of an undisclosed compound from Teva in various cancer indications. The technology uses human tumors implanted i...